Abstract
Age-related macular degeneration (AMD) is responsible for the majority of visual impairment in the Western world. Epidemiological studies examining risk factors for AMD are needed to develop strategies for the prevention of blindness from this condition. A number of potentially modifiable risk factors for AMD have been identified; however, only smoking has been a consistent risk factor across the numerous studies. A growing body of evidence suggests that AMD and cardiovascular disease may have common risk factors. The Cardiovascular Health and Age Related Maculopathy (CHARM) Study was established to examine the risk factors for AMD and its progression, in particular risk factors associated with cardiovascular disease. Examining risk factors for prevalent AMD, cases with AMD were compared with age and gender matched controls with no AMD features. For the assessment of AMD progression, the study examined in 2001 and 2002 those participants with early AMD, or age-related maculopathy (ARM), who had undergone baseline examination between 1992 and 1995 and compared the characteristics of those who had progression of AMD with those who did not. The CHARM study involved both ophthalmic and cardiovascular examinations. Standardised clin...Continue Reading
References
Nov 1, 1976·American Journal of Optometry and Physiological Optics·I L Bailey, J E Lovie
Dec 1, 1992·Archives of Ophthalmology
Dec 1, 1986·Circulation·P PignoliR Paoletti
Feb 1, 1986·Archives of Ophthalmology·R D Sperduto, R Hiller
Mar 1, 1995·Survey of Ophthalmology·A C BirdR Klein
Aug 15, 1995·American Journal of Epidemiology·J R VingerlingP T de Jong
Jun 1, 1996·Ophthalmology·H HirveläL Laatikainen
Dec 1, 1994·Ophthalmic Epidemiology·P M LivingstonH R Taylor
May 2, 1998·Archives of Ophthalmology·R A WilliamsS I Brown
May 22, 1998·Archives of Ophthalmology·W SmithJ J Wang
Jan 20, 1999·The British Journal of Ophthalmology·G ChaineH Bourgeois
Sep 17, 1999·Ophthalmic Epidemiology·G TikellisC A McCarty
Sep 17, 1999·Ophthalmic Epidemiology·S K GarrettH R Taylor
Sep 25, 1999·Archives of Ophthalmology·R KleinA R Folsom
Jan 15, 2000·Archives of Ophthalmology·G C BrownJ Kistler
Jan 21, 2000·Australian and New Zealand Journal of Ophthalmology·L D RobmanC A McCarty
Feb 17, 2000·Archives of Ophthalmology·L M WeihH R Taylor
Mar 18, 2000·Archives of Ophthalmology·L HymanM C Leske
Apr 12, 2001·Ophthalmology·W SmithP T de Jong
Jul 27, 2001·Ophthalmic Epidemiology·C DelcourtUNKNOWN POLA Study Group
Oct 23, 2001·Archives of Ophthalmology·C A McCartyH R Taylor
Jan 4, 2003·Ophthalmology·Ronald KleinLarry D Hubbard
Jun 12, 2003·Ophthalmology·Ronald KleinKaren J Cruickshanks
Citations
Jan 1, 2009·Journal of Ophthalmology·Paul P ConnellStephen Beatty
Dec 24, 2008·BMC Ophthalmology·Catherine A McCartyRobyn Guymer
Apr 4, 2013·American Journal of Epidemiology·Amy C CohnRobyn H Guymer
Nov 11, 2011·Current Eye Research·Rasa LiutkevicieneAbdonas Tamosiunas
Feb 26, 2011·Current Eye Research·Lili YinQing Gu
Nov 13, 2013·Current Eye Research·Alice L YuUlrich Welge-Lussen
Jul 8, 2010·Ophthalmology·Luba RobmanRobyn H Guymer
Mar 26, 2015·Mechanisms of Ageing and Development·Daniela GradinaruGabriel Ioan Prada
Feb 16, 2007·Clinical & Experimental Ophthalmology·Robyn Guymer, Luba Robman
Aug 29, 2007·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Luba RobmanRobyn Guymer
Dec 17, 2008·Experimental Eye Research·Alice L YuUlrich Welge-Lussen
Dec 15, 2016·Acta Ophthalmologica·Antonio PinnaGiuliana Solinas
May 30, 2006·Eye·G TikellisR H Guymer
Feb 3, 2006·Human Mutation·Paul N BairdRobyn H Guymer
Aug 19, 2006·American Journal of Epidemiology·Ammarin ThakkinstianJohn Attia
May 20, 2005·American Journal of Epidemiology·Luba RobmanRobyn Guymer